24 related articles for article (PubMed ID: 38563291)
1. Outcome prediction of SSTR-RADS-3A and SSTR-RADS-3B lesions in patients with neuroendocrine tumors based on
Gao J; Zhou J; Liu C; Pan Y; Lin X; Zhang Y
J Cancer Res Clin Oncol; 2024 May; 150(5):272. PubMed ID: 38795250
[TBL] [Abstract][Full Text] [Related]
2. DOTATATE PET/MR Imaging Differentiates Secondary-Progressive from de Novo World Health Organization Grade 3 Meningiomas.
Kim JT; Chang SJC; Haghdel A; Ramakrishna RR; Pannullo SC; Schwartz TH; Osborne JR; Magge RS; Fine HA; Cisse B; Stieg P; Lin E; Roytman M; Palmer JD; Karakatsanis NA; Pisapia D; Liechty B; Knisely JPS; Ivanidze J
AJNR Am J Neuroradiol; 2024 Jun; 45(6):773-780. PubMed ID: 38604734
[TBL] [Abstract][Full Text] [Related]
3. Different Ectopic Endocrine Tumors on Renal Hilum Detected by 68 Ga-DOTATATE PET.
Lv Y; Lan X; Qin C
Clin Nucl Med; 2024 Jul; 49(7):e367-e369. PubMed ID: 38466019
[TBL] [Abstract][Full Text] [Related]
4. Multifocal Insulinoma as the Unique Presenting Feature of MEN1 in an Adolescent.
Murray A; Rodas Marquez SP; Krishnamurthy M; Lopez-Nunez O; Gurria JP; Trout AT; Almazan S; Mutyala K; Shah A; Howell J
Horm Res Paediatr; 2024 Mar; ():. PubMed ID: 38442699
[TBL] [Abstract][Full Text] [Related]
5. The Utility of Gallium-68 PET/CT in MEN1 Related Parathyroid Disease.
Storan D; Almeamar H; Flynn S; Sherlock M; Colombie M; Skehan SJ; Crowley RK
Eur J Endocrinol; 2024 May; ():. PubMed ID: 38781437
[No Abstract] [Full Text] [Related]
6. Reply to: The Utility of Gallium-68 PET/CT in MEN1 Related Parathyroid Disease.
Kostiainen I; Schildt J; Parviainen H; Ryhänen EM; Schalin-Jäntti C
Eur J Endocrinol; 2024 Jun; ():. PubMed ID: 38828659
[No Abstract] [Full Text] [Related]
7.
AlSadi R; Maaz AUR; Bouhali O; Djekidel M
J Nucl Med Technol; 2023 Jun; 51(2):140-146. PubMed ID: 37192823
[No Abstract] [Full Text] [Related]
8. Semi-automated segmentation methods of SSTR PET for dosimetry prediction in refractory meningioma patients treated by SSTR-targeted peptide receptor radionuclide therapy.
Boursier C; Zaragori T; Bros M; Bordonne M; Melki S; Taillandier L; Blonski M; Roch V; Marie PY; Karcher G; Imbert L; Verger A
Eur Radiol; 2023 Oct; 33(10):7089-7098. PubMed ID: 37148355
[TBL] [Abstract][Full Text] [Related]
9. Role of (68)Ga-DOTATATE PET/CT in patients with multiple endocrine neoplasia type 1 (MEN1).
Lastoria S; Marciello F; Faggiano A; Aloj L; Caracò C; Aurilio M; D'Ambrosio L; Di Gennaro F; Ramundo V; Camera L; De Luca L; Fonti R; Napolitano V; Colao A
Endocrine; 2016 Jun; 52(3):488-94. PubMed ID: 26242621
[TBL] [Abstract][Full Text] [Related]
10. Results of (68)Gallium-DOTATATE PET/CT Scanning in Patients with Multiple Endocrine Neoplasia Type 1.
Sadowski SM; Millo C; Cottle-Delisle C; Merkel R; Yang LA; Herscovitch P; Pacak K; Simonds WF; Marx SJ; Kebebew E
J Am Coll Surg; 2015 Aug; 221(2):509-17. PubMed ID: 26206648
[TBL] [Abstract][Full Text] [Related]
11. 68Ga-DOTATATE PET/CT, 99mTc-HYNIC-octreotide SPECT/CT, and whole-body MR imaging in detection of neuroendocrine tumors: a prospective trial.
Etchebehere EC; de Oliveira Santos A; Gumz B; Vicente A; Hoff PG; Corradi G; Ichiki WA; de Almeida Filho JG; Cantoni S; Camargo EE; Costa FP
J Nucl Med; 2014 Oct; 55(10):1598-604. PubMed ID: 25168627
[TBL] [Abstract][Full Text] [Related]
12. Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT within patients with gastroenteropancreatic neuroendocrine tumors.
Wild D; Bomanji JB; Benkert P; Maecke H; Ell PJ; Reubi JC; Caplin ME
J Nucl Med; 2013 Mar; 54(3):364-72. PubMed ID: 23297077
[TBL] [Abstract][Full Text] [Related]
13. A prospective head-to-head comparison of
Jiang Y; Liu Q; Wang G; Sui H; Wang R; Wang J; Zhu Z
Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4218-4227. PubMed ID: 35657429
[TBL] [Abstract][Full Text] [Related]
14. The lesion detection rate of Ga-68 DOTATATE PET/MR in multiple endocrine neoplasia type 1.
Gao J; Liu C; Zhou J; Pan Y; Zhang Y
J Med Imaging Radiat Oncol; 2024 Apr; 68(3):250-256. PubMed ID: 38563291
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
